Plurogen Therapeutics plurogen.com


Public lists: Pharma Startups (6570)

PluroGen Therapeutics provides clinically advanced and advantaged burn, wound and skin care products. The company works closely with doctors, nurses, patients and healthcare institutions to provide the best products for burn, wound and skin care to help people have a better quality of life. The Company's primary platform is its core PluroGel surfactant technology which provides products with paradigm-shifting, superior and differentiated Core, Bio-Physical, and Performance Functions resulting in...Show all

PluroGen Therapeutics provides clinically advanced and advantaged burn, wound and skin care products. The company works closely with doctors, nurses, patients and healthcare institutions to provide the best products for burn, wound and skin care to h...Show all

Company (Alive / Active)

Phone: 610-539-3670

Fax:

2495 General Armistead Ave

Norristown, 19403
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Plurogen Therapeutics $6.4M Apr 7, 2014
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Plurogen Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Tall Oaks CapitalAsset/Investment ManagementCharlottesville, Virginia, United StatesOther Investors
Batten Institute at the Darden SchoolIncubator/AcceleratorCharlottesville, Virginia, United StatesOther Investors
Jefferson Corner GroupAngel Investor (Group)Charlottesville, Virginia, United StatesSeed VC
Undisclosed InvestorsOtherSeries B - III, Series B - II, Option/Warrant, Series B, Debt
Cato BioVenturesVenture CapitalSan Carlos, California, United StatesSeed VC
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compositions for treating biofilms and methods for using same Feb 16, 2017 Feb 06, 2018 Patent
Compositions for treating biofilms and methods for using same Feb 04, 2016 Mar 28, 2017 Patent
Compositions for treating biofilms and methods for using same Oct 27, 2014 Mar 15, 2016 Patent
Compositions for treating biofilms and methods for using same Nov 26, 2012 Oct 28, 2014 Patent
Compositions and methods of treating microbes Jan 20, 2016 Application
See all 7 patents